{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:14:01Z","timestamp":1769879641512,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jemermed.2020.10.039","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T04:56:33Z","timestamp":1607403393000},"page":"e67-e71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Two Cases of Serotonin Syndrome After Bupropion Overdose Treated With Cyproheptadine"],"prefix":"10.1016","volume":"60","author":[{"given":"Brian P.","family":"Murray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Sayers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Beau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily A.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonya A.","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Kazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2020.10.039_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.jemermed.2020.10.039_bib2","series-title":"Medical Management of Psychotropic Side Effects","first-page":"251","article-title":"Myoclonus and Serotonin Syndrome","author":"Annamalai","year":"2017"},{"key":"10.1016\/j.jemermed.2020.10.039_bib3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2020.10.039_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jclinane.2011.04.017","article-title":"A case of serotonin syndrome precipitated by fentanyl and ondansetron in a patient receiving paroxetine, duloxetine, and bupropion","volume":"24","author":"Gollapudy","year":"2012","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jemermed.2020.10.039_bib5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00002030-200107060-00010","article-title":"Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine","volume":"15","author":"DeSilva","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jemermed.2020.10.039_bib6","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1097\/QAD.0b013e32835a11ba","article-title":"Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient","volume":"26","author":"Lorenzini","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jemermed.2020.10.039_bib7","first-page":"E27","article-title":"Incidence of serotonin syndrome in patients treated with fentanyl on serotonergic agents","volume":"18","author":"Koury","year":"2015","journal-title":"Pain Physician"},{"key":"10.1016\/j.jemermed.2020.10.039_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00004714-199706000-00012","article-title":"Selective serotonin reuptake inhibitor-induced serotonin syndrome: review","volume":"17","author":"Lane","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jemermed.2020.10.039_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2165\/00002018-199717060-00005","article-title":"Drug interactions of clinical significance with selective serotonin reuptake inhibitors","volume":"17","author":"Mitchell","year":"1997","journal-title":"Drug Saf"},{"key":"10.1016\/j.jemermed.2020.10.039_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.wnf.0000142754.46045.8c","article-title":"Serotonin syndrome induced by a combination of bupropion and SSRIs","volume":"27","author":"Munhoz","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jemermed.2020.10.039_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13181-010-0084-8","article-title":"Bupropion, bayesian logic and serotonin toxicity","volume":"6","author":"Gillman","year":"2010","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.jemermed.2020.10.039_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s13181-010-0021-x","article-title":"Bupropion induced serotonin syndrome: a case report","volume":"6","author":"Thorpe","year":"2010","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.jemermed.2020.10.039_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13181-019-00749-4","article-title":"Single-agent bupropion exposures: clinical characteristics and an atypical cause of serotonin toxicity","volume":"16","author":"Murray","year":"2020","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.jemermed.2020.10.039_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchromb.2007.07.007","article-title":"Stereoselective analysis of bupropion and hydroxybupropion in human plasma and urine by LC\/MS\/MS","volume":"857","author":"Coles","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5 Pt 2","key":"10.1016\/j.jemermed.2020.10.039_bib15","first-page":"137","article-title":"Antidepressant response and plasma concentrations of bupropion","volume":"44","author":"Preskorn","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jemermed.2020.10.039_bib16","first-page":"256","article-title":"Seizures and bupropion: a review","volume":"50","author":"Davidson","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jemermed.2020.10.039_bib17","series-title":"Wellbutrin XL (bupropion hydrochloride) (package insert)","year":"2019"},{"key":"10.1016\/j.jemermed.2020.10.039_bib18","series-title":"Zyban (bupropion hydrochloride) (package insert)","year":"2019"},{"key":"10.1016\/j.jemermed.2020.10.039_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1994.43","article-title":"Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism","volume":"11","author":"Cooper","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jemermed.2020.10.039_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ddr.430010103","article-title":"Some neurochemical properties of a new antidepressant, bupropion hydrochloride (Wellbutrin\u2122)","volume":"1","author":"Ferris","year":"1981","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.jemermed.2020.10.039_bib21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0028-3908(83)90198-3","article-title":"Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain","volume":"22","author":"Ferris","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jemermed.2020.10.039_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1586\/14737175.6.9.1249","article-title":"Bupropion: pharmacology and therapeutic applications","volume":"6","author":"Foley","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jemermed.2020.10.039_bib23","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuropharm.2005.05.004","article-title":"Bupropion increases striatal vesicular monoamine transport","volume":"49","author":"Rau","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jemermed.2020.10.039_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s002130000665","article-title":"Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment","volume":"155","author":"Dong","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jemermed.2020.10.039_bib25","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.neuropharm.2008.07.028","article-title":"Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain","volume":"55","author":"El Mansari","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jemermed.2020.10.039_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-011-2260-1","article-title":"Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion","volume":"217","author":"Ghanbari","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jemermed.2020.10.039_bib27","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/sj.npp.1300489","article-title":"Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus","volume":"29","author":"Haddjeri","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jemermed.2020.10.039_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0735-6757(94)90195-3","article-title":"Bupropion overdose: a 3-year multi-center retrospective analysis","volume":"12","author":"Spiller","year":"1994","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2020.10.039_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ADM.0000000000000249","article-title":"Bupropion \"abuse\" reported to US poison centers","volume":"10","author":"Stassinos","year":"2016","journal-title":"J Addict Med"},{"key":"10.1016\/j.jemermed.2020.10.039_bib30","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/0009922817737082","article-title":"Nonepileptic myoclonus following bupropion overdose","volume":"57","author":"Xiang","year":"2018","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jemermed.2020.10.039_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ajem.2008.07.004","article-title":"Incidence and onset of delayed seizures after overdoses of extended-release bupropion","volume":"27","author":"Starr","year":"2009","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2020.10.039_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/15563650.2020.1742919","article-title":"Bupropion associated seizures following acute overdose: who develops late seizures","author":"Offerman","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jemermed.2020.10.039_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/15563650.2019.1699658","article-title":"Clinical characteristics and outcomes associated with bupropion overdose: a Canadian perspective","author":"Stewart","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jemermed.2020.10.039_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1472-8206.2011.00953.x","article-title":"QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile","volume":"26","author":"Caillier","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jemermed.2020.10.039_bib35","first-page":"1","article-title":"Serotonin toxicity from isolated bupropion overdoses","author":"Sidlak","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jemermed.2020.10.039_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/15563650.2020.1767783","article-title":"Comment on serotonin toxicity from isolated bupropion overdoses","author":"Taub","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jemermed.2020.10.039_bib37","article-title":"Response to Taub et\u00a0al","author":"Sidlak","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jemermed.2020.10.039_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jemermed.2004.02.017","article-title":"Intentional bupropion overdoses","volume":"27","author":"Shepherd","year":"2004","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2020.10.039_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1345\/aph.10203","article-title":"Serotonin syndrome: early management with cyproheptadine","volume":"35","author":"McDaniel","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jemermed.2020.10.039_bib40","series-title":"Poisoning & Drug Overdose","author":"Olson","year":"2017"},{"key":"10.1016\/j.jemermed.2020.10.039_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jcpt.12796","article-title":"An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System","volume":"44","author":"Nguyen","year":"2019","journal-title":"J Clin Pharm Ther"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467920310878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467920310878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:47:43Z","timestamp":1760028463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467920310878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0736467920310878"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2020.10.039","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two Cases of Serotonin Syndrome After Bupropion Overdose Treated With Cyproheptadine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2020.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}